Search for Clinical Trial Results
Carcinoma, Islet Cell - 25 Studies Found
Status | Study |
Terminated |
Study Name: A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors Condition:
Date: 2007-01-29 Interventions:
|
Recruiting |
Study Name: Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II Condition: Pancreatic Neuroendocrine Carcinoma Date: 2014-08-27 Interventions:
|
Completed |
Study Name: RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma Condition:
Date: 2005-06-07 Interventions:
|
Active, not recruiting |
Study Name: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer Condition:
|
Withdrawn |
Study Name: Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors Condition:
Interventions:
|
Completed |
Study Name: A Study of IMC-A12 in Islet Cell Cancer Condition:
Date: 2008-10-27 Interventions:
|
Active, not recruiting |
Study Name: Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery Condition:
|
Recruiting |
Study Name: Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery Condition:
Date: 1999-11-03 Interventions: Drug: Interferon |
Recruiting |
Study Name: Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery Condition:
|